Correction to: British Journal of Cancer (2002) 87, 630–634. doi:10.1038/sj.bjc.6600511
Unfortunately due to a typesetting error, Figure 2 was reproduced uncorrectly.
The correct version is reprinted below:
The publisher would like to apologise for any inconvenience this may have caused.
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
Additional information
The online version of the original article can be found at 10.1038/sj.bjc.6600511
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Boulay, JL., Mild, G., Lowy, A. et al. Erratum: SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br J Cancer 89, 422 (2003). https://doi.org/10.1038/sj.bjc.6601020
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6601020